NeOnc Technologies secured a January 2027 FDA meeting to discuss accelerated approval for its experimental brain cancer drug NEO100, following positive Phase 2a trial results showing improved progression-free survival. The company aims to seek feedback on using existing data for a New Drug Application and plans a Phase 3 trial comparing NEO100 to standard chemotherapy. Insider stock purchases and upcoming clinical presentations add investor interest. The FDA meeting and trial progress could significantly impact NeOnc's regulatory path and market potential.
NeOnc Technologies' FDA meeting for its experimental brain cancer drug NEO100 is the story's focus, with Pluang's health sector data providing market context. As of Nov 11, 2026 20:11 WIB, out of 150 priced health-sector US stocks on Pluang, 69 rose and 74 fell. Among notable movers, DNA (Ginkgo Bioworks Holdings Inc) rose 4.00% to USD 12.49 with balanced buy/sell activity, RXRX (Recursion Pharmaceuticals Inc) increased 3.93% to USD 3.70 with 100% buy orders, and TXG (10X Genomics Inc) gained 3.39% to USD 65.03 with 82% buy orders and a typical hold time of 92 days.
The global telehealth market, valued at $77.4 billion in 2025, is projected to expand to $187.5 billion by 2033, driven by increasing patient demand for virtual care and advances in AI, remote monitoring, and wearable health devices. Companies like R...
The Portnoy Law Firm is investigating Arbor Realty Trust, Inc. for possible securities fraud following the company's October 30, 2026 announcement to suspend its quarterly cash dividend due to financial challenges. This announcement caused Arbor's st...
RUM Group Inc. reported a record quarterly revenue of $96.6 million for Q3 2026, a 290% increase year-over-year, surpassing expectations. Despite this, earnings per share were -$0.19, missing the estimate of -$0.11. The company achieved its first pro...
Richtech Robotics announced its Intelligent Cleaning System at ISSA Show North America 2026, which integrates autonomous cleaning robots with CCTV cameras to enable proactive, targeted cleaning. This system uses real-time data to optimize cleaning ta...
The 2026 Vertex CompOps™ Index reveals that just 16% of enterprises regularly discuss indirect tax at the board level, while 43% only address it when issues arise. Companies with board-level focus on indirect tax are four times less likely to have er...
